U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07425262) titled 'A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension' on Feb. 15.
Brief Summary: To evaluate the epidemiological status of traditional Chinese Medicine (TCM) constitution in patients with dialysis hypotension, and design a clinical study based on a common syndrome-based herbal formulation to evaluate the clinical efficacy and safety of TCM
Study Start Date: Feb. 02
Study Type: INTERVENTIONAL
Condition:
End Stage Renal Disease on Dialysis
Intradialytic Hypotension
Intervention:
DRUG: CHM intervention group
Jia Wei Sheng Yu Si Ni Tang (JWSYSNT) powder, 4.5 gm per dose, taken orally 2 times a day, for 8 weeks...